Found: 45
Select item for more details and to access through your institution.
Prognostic impact of HER3 based on protein and mRNA expression in high-grade serous ovarian carcinoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
NGS-based BRCA1/2 mutation testing of high-grade serous ovarian cancer tissue: results and conclusions of the first international round robin trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Vascular endothelial growth factor receptor 2 (VEGFR2) correlates with long-term survival in patients with advanced high-grade serous ovarian cancer (HGSOC): a study from the Tumor Bank Ovarian Cancer (TOC) Consortium.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2019, v. 145, n. 4, p. 1063, doi. 10.1007/s00432-019-02877-4
- By:
- Publication type:
- Article
Predictive value of sphingosine kinase 1 expression in neoadjuvant treatment of breast cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2013, v. 139, n. 10, p. 1681, doi. 10.1007/s00432-013-1490-5
- By:
- Publication type:
- Article
Phospho-mTOR and phospho-4EBP1 in endometrial adenocarcinoma: association with stage and grade in vivo and link with response to rapamycin treatment in vitro.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2009, v. 135, n. 7, p. 933, doi. 10.1007/s00432-008-0529-5
- By:
- Publication type:
- Article
Expression, Intracellular Localization, and Prognostic Value of Plasminogen Activator Inhibitor 1 and PAI-1 RNA-Binding Protein 1 in Primary and Recurrent Ovarian Cancer: A Study of the Tumor Bank Ovarian Cancer Network.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Lymph Node Involvement Pattern and Survival Differences of FIGO IIIC and FIGO IIIA1 Ovarian Cancer Patients After Primary Complete Tumor Debulking Surgery: A 10-Year Retrospective Analysis of the Tumor Bank Ovarian Cancer Network.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2016, v. 23, n. 4, p. 1279, doi. 10.1245/s10434-015-4959-4
- By:
- Publication type:
- Article
Prognostic significance of Dicer expression in ovarian cancer-link to global microRNA changes and oestrogen receptor expression.
- Published in:
- Journal of Pathology, 2010, v. 220, n. 3, p. 382, doi. 10.1002/path.2658
- By:
- Publication type:
- Article
A prognostic gene expression index in ovarian cancer-validation across different independent data sets.
- Published in:
- Journal of Pathology, 2009, v. 218, n. 2, p. 273, doi. 10.1002/path.2547
- By:
- Publication type:
- Article
Stable expansion of high‐grade serous ovarian cancer organoids requires a low‐Wnt environment.
- Published in:
- EMBO Journal, 2020, v. 39, n. 6, p. 1, doi. 10.15252/embj.2019104013
- By:
- Publication type:
- Article
Role of TRAP1 and estrogen receptor alpha in patients with ovarian cancer -A study of the OVCAD consortium.
- Published in:
- Molecular Cancer, 2012, v. 11, n. 1, p. 69, doi. 10.1186/1476-4598-11-69
- By:
- Publication type:
- Article
PIK3CA H1047R Mutation Associated with a Lower Pathological Complete Response Rate in Triple-Negative Breast Cancer Patients Treated with Anthracycline-Taxane-Based Neoadjuvant Chemotherapy.
- Published in:
- Cancer Research & Treatment, 2020, v. 52, n. 3, p. 689, doi. 10.4143/crt.2019.497
- By:
- Publication type:
- Article
Prospective Validation of Immunological Infiltrate for Prediction of Response to Neoadjuvant Chemotherapy in HER2-Negative Breast Cancer – A Substudy of the Neoadjuvant GeparQuinto Trial.
- Published in:
- PLoS ONE, 2013, v. 8, n. 12, p. 1, doi. 10.1371/journal.pone.0079775
- By:
- Publication type:
- Article
Cutoff Finder: A Comprehensive and Straightforward Web Application Enabling Rapid Biomarker Cutoff Optimization.
- Published in:
- PLoS ONE, 2012, v. 7, n. 12, p. 1, doi. 10.1371/journal.pone.0051862
- By:
- Publication type:
- Article
Neutrophil Gelatinase-Associated Lipocalin (NGAL) Predicts Response to Neoadjuvant Chemotherapy and Clinical Outcome in Primary Human Breast Cancer.
- Published in:
- PLoS ONE, 2012, v. 7, n. 10, p. 1, doi. 10.1371/journal.pone.0045826
- By:
- Publication type:
- Article
Anti-cancer immune response mechanisms in neoadjuvant and targeted therapy.
- Published in:
- Seminars in Immunopathology, 2011, v. 33, n. 4, p. 341, doi. 10.1007/s00281-011-0261-0
- By:
- Publication type:
- Article
Classification of Molecular Subtypes of High-Grade Serous Ovarian Cancer by MALDI-Imaging.
- Published in:
- Cancers, 2021, v. 13, n. 7, p. 1512, doi. 10.3390/cancers13071512
- By:
- Publication type:
- Article
Discovery of Prognostic Markers for Early-Stage High-Grade Serous Ovarian Cancer by Maldi-Imaging.
- Published in:
- Cancers, 2020, v. 12, n. 8, p. 2000, doi. 10.3390/cancers12082000
- By:
- Publication type:
- Article
Responsiveness of adjacent ductal carcinoma in situ and changes in HER2 status after neoadjuvant chemotherapy/trastuzumab treatment in early breast cancer-results from the GeparQuattro study (GBG 40).
- Published in:
- Breast Cancer Research & Treatment, 2012, v. 132, n. 3, p. 863, doi. 10.1007/s10549-011-1621-0
- By:
- Publication type:
- Article
Androgen receptor expression in primary breast cancer and its predictive and prognostic value in patients treated with neoadjuvant chemotherapy.
- Published in:
- Breast Cancer Research & Treatment, 2011, v. 130, n. 2, p. 477, doi. 10.1007/s10549-011-1715-8
- By:
- Publication type:
- Article
Effect of neoadjuvant anthracycline-taxane-based chemotherapy in different biological breast cancer phenotypes: overall results from the GeparTrio study.
- Published in:
- Breast Cancer Research & Treatment, 2011, v. 124, n. 1, p. 133, doi. 10.1007/s10549-010-1103-9
- By:
- Publication type:
- Article
HER2 and ESR1 mRNA expression levels and response to neoadjuvant trastuzumab plus chemotherapy in patients with primary breast cancer.
- Published in:
- Breast Cancer Research, 2013, v. 15, n. 1, p. 1, doi. 10.1186/bcr3384
- By:
- Publication type:
- Article
HER2 and ESR1 mRNA expression levels and response to neoadjuvant trastuzumab plus chemotherapy in patients with primary breast cancer.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Morphology and tumour‐infiltrating lymphocytes in high‐stage, high‐grade serous ovarian carcinoma correlated with long‐term survival.
- Published in:
- Histopathology, 2018, v. 73, n. 6, p. 1002, doi. 10.1111/his.13711
- By:
- Publication type:
- Article
Evaluation of a hormone receptor-positive ovarian carcinoma subtype with a favourable prognosis by determination of progesterone receptor and oestrogen receptor 1 mRNA expression in formalin-fixed paraffin-embedded tissue.
- Published in:
- Histopathology, 2011, v. 59, n. 5, p. 918, doi. 10.1111/j.1365-2559.2011.04028.x
- By:
- Publication type:
- Article
Expression of classical NF-κB pathway effectors in human ovarian carcinoma.
- Published in:
- Histopathology, 2010, v. 56, n. 6, p. 727, doi. 10.1111/j.1365-2559.2010.03544.x
- By:
- Publication type:
- Article
Expression of multidrug resistance-associated protein 1 in invasive ovarian carcinoma: implication for prognosis.
- Published in:
- Histopathology, 2009, v. 54, n. 6, p. 657, doi. 10.1111/j.1365-2559.2009.03297.x
- By:
- Publication type:
- Article
Checkpoint-inhibition in ovarian cancer: rising star or just a dream?
- Published in:
- Journal of Gynecologic Oncology, 2018, v. 29, n. 6, p. 1, doi. 10.3802/jgo.2018.29.e93
- By:
- Publication type:
- Article
Overexpression of the epithelial cell adhesion molecule is associated with a more favorable prognosis and response to platinum-based chemotherapy in ovarian cancer.
- Published in:
- Journal of Gynecologic Oncology, 2014, v. 25, n. 3, p. 221, doi. 10.3802/jgo.2014.25.3.221
- By:
- Publication type:
- Article
Characterisation of homologous recombination deficiency in paired primary and recurrent high-grade serous ovarian cancer.
- Published in:
- British Journal of Cancer, 2018, v. 119, n. 9, p. 1060, doi. 10.1038/s41416-018-0268-6
- By:
- Publication type:
- Article
Characterisation of homologous recombination deficiency in paired primary and recurrent high-grade serous ovarian cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Characterisation of tumour microvessel density during progression of high-grade serous ovarian cancer: clinico-pathological impact (an OCTIPS Consortium study).
- Published in:
- 2018
- By:
- Publication type:
- journal article
Methylation of MYLK3 gene promoter region: a biomarker to stratify surgical care in ovarian cancer in a multicentre study.
- Published in:
- British Journal of Cancer, 2017, v. 116, n. 10, p. 1287, doi. 10.1038/bjc.2017.83
- By:
- Publication type:
- Article
Methylation of MYLK3 gene promoter region: a biomarker to stratify surgical care in ovarian cancer in a multicentre study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Mutational profiles of Brenner tumors show distinctive features uncoupling urothelial carcinomas and ovarian carcinoma with transitional cell histology.
- Published in:
- Genes, Chromosomes & Cancer, 2017, v. 56, n. 10, p. 758, doi. 10.1002/gcc.22480
- By:
- Publication type:
- Article
Pan-cancer analysis of copy number changes in programmed death-ligand 1 (PD-L1, CD274) - associations with gene expression, mutational load, and survival.
- Published in:
- Genes, Chromosomes & Cancer, 2016, v. 55, n. 8, p. 626, doi. 10.1002/gcc.22365
- By:
- Publication type:
- Article
Vascular endothelial growth factor C mRNA expression is a prognostic factor in epithelial ovarian cancer as detected by kinetic RT-PCR in formalin-fixed paraffin-embedded tissue.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2009, v. 455, n. 6, p. 461, doi. 10.1007/s00428-009-0851-6
- By:
- Publication type:
- Article
Discovery and Validation of Novel Biomarkers for Detection of Epithelial Ovarian Cancer.
- Published in:
- Cells (2073-4409), 2019, v. 8, n. 7, p. 713, doi. 10.3390/cells8070713
- By:
- Publication type:
- Article
Gross cystic disease fluid protein 15 (GCDFP-15) expression in breast cancer subtypes.
- Published in:
- BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-546
- By:
- Publication type:
- Article
Gross cystic disease fluid protein 15 (GCDFP-15) expression in breast cancer subtypes
- Published in:
- BMC Cancer, 2014, v. 14, n. 1, p. 546, doi. 10.1186/1471-2407-14-546
- By:
- Publication type:
- Article
Disseminated pulmonary AL amyloidosis associated with lymphoplasmacytic lymphoma.
- Published in:
- EJHaem, 2021, v. 2, n. 3, p. 644, doi. 10.1002/jha2.193
- By:
- Publication type:
- Article
Front Cover: MALDI‐Imaging for Classification of Epithelial Ovarian Cancer Histotypes from a Tissue Microarray Using Machine Learning Methods.
- Published in:
- Proteomics - Clinical Applications, 2019, v. 13, n. 1, p. N.PAG, doi. 10.1002/prca.201970011
- By:
- Publication type:
- Article
MALDI‐Imaging for Classification of Epithelial Ovarian Cancer Histotypes from a Tissue Microarray Using Machine Learning Methods.
- Published in:
- Proteomics - Clinical Applications, 2019, v. 13, n. 1, p. N.PAG, doi. 10.1002/prca.201700181
- By:
- Publication type:
- Article
Gross cystic disease fluid protein 15 (GCDFP-15) expression in breast cancer subtypes.
- Published in:
- 2014
- By:
- Publication type:
- journal article
An intracellular targeted antibody detects EGFR as an independent prognostic factor in ovarian carcinomas.
- Published in:
- BMC Cancer, 2011, v. 11, n. 1, p. 294, doi. 10.1186/1471-2407-11-294
- By:
- Publication type:
- Article